Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Membrane Fluidity01:23

Membrane Fluidity

151.9K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
151.9K
Conjugated Proteins02:50

Conjugated Proteins

18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Efficiency and immunogenicity of lipid nanoparticle-mediated cardiac mRNA delivery are lipid composition-dependent.

Molecular therapy. Nucleic acids·2026
Same author

Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe.

British journal of clinical pharmacology·2026
Same author

Evaluation of Tetraspanins in Extracellular Vesicle Bioengineering.

Small science·2026
Same author

Longitudinal 3D-DCE MRI Assessment of Placental Perfusion Under Reduced Uterine Perfusion Pressure in Pregnant Rats.

NMR in biomedicine·2026
Same author

Magnetic Lipid Nanoparticles for Targeted mRNA Delivery and Enhanced Organ-Specific Expression.

ACS applied materials & interfaces·2026
Same author

Toward <i>In Vivo</i> CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design.

Nano letters·2026

相关实验视频

Updated: Jun 20, 2025

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
00:11

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

23.7K

生物流体特异性蛋白质冠冕在体外影响脂质纳米颗粒的行为.

Demian van Straten1, Helena Sork2, Luuk van de Schepop1

  • 1CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.

Journal of controlled release : official journal of the Controlled Release Society
|July 20, 2024
PubMed
概括

脂质纳米颗粒 (LNP) 在脑脊液 (CSF) 和血中形成不同的蛋白质冠状. 这改变了细胞吸收,突显了LNP基因治疗疗效的注射部位的重要性.

关键词:
生物流体是一种生物流体.脑子 脑子 脑子 脑子标志性描述 标志性描述脂质纳米颗粒的使用方法蛋白质冠状病毒的冠状病毒配送RNA配送RNA的时间

更多相关视频

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.1K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.8K

相关实验视频

Last Updated: Jun 20, 2025

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
00:11

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

23.7K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.1K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.8K

科学领域:

  • 生物医学工程 生物医学工程
  • 纳米技术 纳米技术
  • 药物运输 药物运输 药物运输

背景情况:

  • 脂质纳米颗粒 (LNP) 已被用于mRNA/siRNA疗法,包括COVID-19疫苗.
  • 在体内LNP行为的理解,特别是通过蛋白冠状的细胞向,仍然有限.
  • 组织特异性蛋白质冠状体来自不同的注射部位,影响LNP的特性.

研究的目的:

  • 为了研究人类脑脊液 (CSF) 和血中LNP上形成的蛋白质冠状元的差异.
  • 评估CSF衍生的蛋白质冠状体对LNP细胞吸收的影响.
  • 评估是否改变了细胞吸收转化为改善的货物交付.

主要方法:

  • 在人体血和人脑脊髓液中化临床相关的LNP配方.
  • 由此产生的蛋白质冠状体的蛋白质组学分析 (血衍生与CSF衍生).
  • 在体外评估不同蛋白质冠冕的细胞吸收LNP.

主要成果:

  • 在CSF (C-LNPs) 中化的LNP与血 (P-LNPs) 中的LNP相比,呈现出不同的冠状蛋白组成.
  • 在C-LNP冠状病毒中,Apolipoprotein E和脂蛋白更为丰富.
  • 与P-LNP相比,C-LNP显示细胞吸收增强,无论细胞类型如何.

结论:

  • 生物流体特异性蛋白质冠状体显著改变了LNP的功能.
  • 由于差异化冠状形成,LNP施用地点可能会影响治疗疗效.
  • 需要进行进一步的研究,以将增强的蜂接收与实际货物交付效率相关联.